The SOGC Statement on the WHI Report On Estrogen and Progestin Use in Postmenopausal Women
- 1 October 2002
- journal article
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 24 (10) , 783-787
- https://doi.org/10.1016/s1701-2163(16)30471-6
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus ProgestinJNCI Journal of the National Cancer Institute, 2000
- Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer RiskJAMA, 2000
- Hormonal Contraception and Risk of Cardiovascular DiseaseContraception, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997